Neuroprotective effect of the surfactant poloxamer 188 in a model of intracranial hemorrhage in rats

Journal of Neurosurgery

Volumn 106, Issue 1 SUPPL., 2007, Pages 36-40

  Cadichon, Sandra B ^a,b   Le, Hoang M ^a   Wright, David A ^a   Curry, Daniel J ^a   Kang, Un ^a   Frim, David M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Intraparenchymal hemorrhage; Neuroprotection; Pediatric neurosurgery; Poloxamer 188; Rat

Indexed keywords

NEUROPROTECTIVE AGENT; POLOXAMER; SURFACTANT;

ANIMAL; ARTICLE; BRAIN HEMORRHAGE; CELL SURVIVAL; CISTERNA MAGNA; COMPARATIVE STUDY; CORPUS STRIATUM; DISEASE MODEL; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LIPID PEROXIDATION; MALE; NERVE CELL; OXIDATIVE STRESS; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; SYNAPTIC MEMBRANE;

ANIMALS; CELL SURVIVAL; CEREBRAL HEMORRHAGE, TRAUMATIC; CISTERNA MAGNA; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; INJECTIONS, INTRAVENTRICULAR; LIPID PEROXIDATION; MALE; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; POLOXAMER; RATS; RATS, SPRAGUE-DAWLEY; SURFACE-ACTIVE AGENTS; SYNAPTIC MEMBRANES;

EID: 33846905984     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/jns.2007.106.1.36     Document Type: Article

References (35)

1. Ardizzone TD, Lu A, Wagner KR, Tang Y, Ran R, Sharp FR: Glutamate receptor blockade attenuates glucose hypermetabolism in perihematomal brain after experimental intracerebral hemorrhage in rat. Stroke 35:2587-2591, 2004 (Pubitemid 39458422)
2. Armstrong JK, Meiselman HJ, Fisher TC: Inhibition of red blood cell-induced platelet aggregation in whole blood by a nonionic surfactant, poloxamer 188 (RheothRx injection). Thromb Res 79:437-450, 1995
3. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, et al: A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 322:1405-1411, 1990 (Pubitemid 20152525)
4. Bracken MB, Shepard MJ, Collins WF Jr, Holford TR, Baskin DS, Eisenberg HM, et al: Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. J Neurosurg 76:23-31, 1992
5. Bullock MR, Merchant RE, Carmack CA, Doppenberg E, Shah AK, Wilner KD, et al: An open-label study of CP-101, 606 in subjects with a severe traumatic head injury or spontaneous intracerebral hemorrhage. Ann N Y Acad Sci 890:51-58, 1999 (Pubitemid 30040364)
6. Carr ME Jr, Powers PL, Jones MR: Effects of poloxamer 188 on the assembly, structure and dissolution of fibrin clots. Thromb Haemost 66:565-568, 1991
7. Chen MH, Bullock R, Graham DI, Miller JD, McCulloch J: Ischemic neuronal damage after acute subdural hematoma in the rat: effects of pretreatment with a glutamate antagonist. J Neurosurg 74:944-950, 1991
8. Colbassani HJ, Barrow DL, Sweeney KM, Bakay RA, Check IJ, Hunter RL: Modification of acute focal ischemia in rabbits by poloxamer 188. Stroke 20:1241-1246, 1989 (Pubitemid 19226921)
9. Curry DJ, Wright DA, Lee RC, Kang UJ, Frim DM: Poloxamer 188 volumetrically decreases neuronal loss in the rat in a timedependent manner. Neurosurgery 55:943-949, 2004 (Pubitemid 39315043)
10. Del Bigio MR, Yan HJ, Buist R, Peeling J: Experimental intracerebral hemorrhage in rats. Magnetic resonance imaging and histopathological correlates. Stroke 27:2312-2320, 1996 (Pubitemid 26427211)
11. Frim DM, Wright DA, Curry DJ, Cromie W, Lee R, Kang UJ: The surfactant poloxamer-188 protects against glutamate toxicity in the rat brain. Neuroreport 15:171-174, 2004 (Pubitemid 41614993)
12. Gibbs WJ, Hagemann TM: Purified poloxamer 188 for sickle cell vaso-occlusive crisis. Ann Pharmacother 38:320-324, 2004 (Pubitemid 38112248)
13. Gong C, Hoff JT, Keep RF: Acute inflammatory reaction following experimental intracerebral hemorrhage in rat. Brain Res 871:57-65, 2000 (Pubitemid 30406868)
14. Grindel JM, Jaworski T, Piraner O, Emanuele RM, Balasubramanian M: Distribution, metabolism, and excretion of a novel surface-active agent, purified poloxamer 188, in rats, dogs, and humans. J Pharm Sci 91:1936-1947, 2002 (Pubitemid 36254930)
15. Härtl R, Schürer L, Schmid-Schönbein GW, del Zoppo GJ: Experimental antileukocyte interventions in cerebral ischemia. J Cereb Blood Flow Metab 16:1108-1119, 1996 (Pubitemid 26365361)
16. Howell JM, Dhindsa HS, Stair TO, Edwards BA: Effect of scrubbing and irrigation on staphylococcal and streptococcal counts in contaminated lacerations. Antimicrob Agents Chemother 37:2754-2755, 1993 (Pubitemid 23357882)
17. Jenkins A, Mendelow AD, Graham DI, Nath FP, Teasdale GM: Experimental intracerebral haematoma: the role of blood constituents in early ischaemia. Br J Neurosurg 4:45-51, 1990
18. Jewell RC, Khor SP, Kisor DF, Lacroix KAK, Wargin WA: Pharmacokinetics of rheothrx injection in healthy male volunteers. J Pharm Sci 86:808-812, 1997 (Pubitemid 27297492)
19. Kane PJ, Modha P, Strachan RD, Cook S, Chambers IR, Clayton CB, et al: The effect of immunosuppression on the development of cerebral oedema in an experimental model of intracerebral haemorrhage: whole body and regional irradiation. J Neurol Neurosurg Psychiatry 55:781-786, 1992
20. Lee RC, River LP, Pan F, Ji L, Wollmann RL: Surfactantinduced sealing of electropermeabilized skeletal muscle membranes in vivo. Proc Natl Acad Sci U S A 89:4524-4528, 1992
21. Marks JD, Pan CY, Bushell T, Cromie W, Lee RC: Amphiphilic, tri-block copolymers provide potent membrane-targeted neuroprotection. FASEB J 15:1107-1109, 2001
22. Maskarinec SA, Hannig J, Lee RC, Lee KYC: Direct observation of poloxamer 188 insertion into lipid monolayers. Biophys J 82:1453-1459, 2002 (Pubitemid 34204765)
23. Miyanchi Y, Inoue T, Paton BC: Adjunctive use of a surface active agent in extracorporeal oxygenators. Circulation 33/34 (Suppl):171-177, 1966
24. Orringer EP, Casella JF, Ataga KI, Koshy M, Adams-Graves P, Luchtman-Jones L, et al: Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: a randomized controlled trial. JAMA 286:2099-2106, 2001 (Pubitemid 34041594)
25. Pantoni L, Sarti C, Inzitari D: Cytokines and cell adhesion molecules in cerebral ischemia: experimental bases and therapeutic perspectives. Arterioscler Thromb Vasc Biol 18:503-513, 1998 (Pubitemid 28177888)
26. Regan RF, Panter SS: Hemoglobin potentiates excitotoxic injury in cortical cell culture. J Neurotrauma 13:223-231, 1996 (Pubitemid 26142615)
27. Regan RF, Panter SS: Neurotoxicity of hemoglobin in cortical cell culture. Neurosci Lett 153:219-222, 1993 (Pubitemid 23147074)
28. Sadrzadeh SM, Anderson DK, Panter SS, Hallaway PE, Eaton JW: Hemoglobin potentiates central nervous system damage. J Clin Invest 79:662-664, 1987 (Pubitemid 17009711)
29. Schaer GL, Hursey TL, Abrahams SL, Buddemeier K, Ennis B, Rodriguez ER, et al: Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function. Circulation 90:2964-2975, 1994
30. Schaer GL, Spaccavento LJ, Browne KF, Krueger KA, Krichbaum D, Phelan JM, et al: Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial. Circulation 94:298-307, 1996 (Pubitemid 26266112)
31. Tan J, Saltzman WM: Influence of synthetic polymers on neutrophil migration in three-dimensional collagen gels. J Biomed Mater Res 46:465-474, 1999
32. Wahlgren NG, Ahmed N: Neuroprotection in cerebral ischaemia: facts and fancies-the need for new approaches. Cerebrovasc Dis 17 (1 Suppl):153-166, 2004 (Pubitemid 38032534)
33. Xue M, Del Bigio MR: Intracerebral injection of autologous whole blood in rats: time course of inflammation and cell death. Neurosci Lett 283:230-232, 2000 (Pubitemid 30168975)
34. Xue M, Del Bigio MR: Intracortical hemorrhage injury in rats: relationship between blood fractions and brain cell death. Stroke 31:1721-1727, 2000 (Pubitemid 30437529)
35. Yilmazlar S, Hanci M, Oz B, Kuday C: Blood degradation products play a role in cerebral ischemia caused by acute subdural hematoma. J Neurosurg Sci 41:379-385, 1997 (Pubitemid 28138848)